Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc. (KPTI) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · KPTI · as of Jun 9, 2026
Key Statistics
Explore Karyopharm Therapeutics Inc. Data
kpti stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 20 · Buy rate: 70.0%
The KPTI analyst consensus is Buy, based on ratings from 20 Wall Street analysts over the past 3 months. The average 12-month price target is $17.25, representing +102.94% upside from the current price of $8.50.
Competitors & Peers
kpti competitorsKPTI
ALGS
BRNS
CVM
FGEN
INMBStock Performance
Full HistoryAbout Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc. is a pharmaceutical company that has already brought products to market, focusing on identifying, advancing, and selling medications designed to disrupt nuclear export pat…
what is karyopharm therapeutics inc. · kpti stock overview · karyopharm therapeutics inc. company profile · who is karyopharm therapeutics inc. ceo · kpti NASDAQ · karyopharm therapeutics inc. headquarters · karyopharm therapeutics inc. business segments
About Stock Overview & Key Data
Karyopharm Therapeutics Inc. (KPTI) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 6, 2013. As of the latest trading session, KPTI stock price is $8.50, with a market capitalization of $192.6M. The stock has returned +101.90% over the past 12 months and +15.49% year-to-date.
According to 20 Wall Street analysts, the consensus rating for Karyopharm Therapeutics Inc. stock is Buy, with an average 12-month price target of $17.25. In fiscal year 2025, Karyopharm Therapeutics Inc. reported revenue of $146.1M and net income of -$196.0M. For detailed data — including Karyopharm Therapeutics Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Karyopharm Therapeutics Inc. (KPTI) stock price is $8.50. The stock is traded on NASDAQ under the ticker symbol KPTI. The 52-week range is $3.65 – $10.99.